At 3 years of age, when the majority of serotype-specific differences were non-significant, the overall estimates calculated using multivariate methods were all highly significant regardless of whether weighted equally or whether unequal weighting structures were applied.
← all excerpts
Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences.
1
—
—